GlassScriptPhysician profile
Karim Salame
NPI 1215190681
$4,008.04
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,009 · 2022: $509 · 2023: $1,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,188 · Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,187.50 |
| Food and Beverage | $301.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $2,009.43 | 2019 | |
| Argenx US, INC. | $1,291.03 | 2022-2023 | Vyvgart |
| Alexion Pharmaceuticals, INC. | $232.09 | 2022-2023 | |
| Genentech USA, INC. | $146.05 | 2022 | |
| Biogen, INC. | $133.85 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $109.85 | 2023 | Ajovy |
| Abbvie INC. | $73.58 | 2023 | Botox |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Salame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.